The Asia-Pacific drug discovery informatics market is projected to grow at a significant CAGR of 10.8% during the forecast period (2020-2026). The growing demand for cloud-based solutions in the pharmaceutical sector in various countries such as China, India, and Japan further provide a significant opportunity to the drug discovery informatics market in the region. The significant adoption of the NGS technologies for clinical research further increases the need for cloud technologies. The increasing presence of major cloud service providers, including IBM Corp. and Microsoft Corp. will likely offer an opportunity to accelerate demand for cloud platforms coupled with informatics tools in the emerging pharmaceutical industry in the region.
(Get 15% Discount on Buying this Report)
A full report of Asia-Pacific Drug Discovery Informatics Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-drug-discovery-informatics-market
Moreover, the integration of AI technology in the healthcare sector in the region further provides substantial opportunity to the drug discovery informatics market. For instance, in January 2018, the Government of China has planned to invest $2.12 billion in the development of an AI technology park near Beijing. The park aims to promote companies working in the field of big data, deep learning, and cloud computing. Alibaba Group is one of the major players working in the field of medical cloud computing and AI in the country. In 2016, Alibaba Cloud team up with Intel and BGI Genomics to initiate a bioinformatics analysis platform that will be able to sequence the entire human genome within a day.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-drug-discovery-informatics-market
Market Coverage
- The market number available for – 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segments Covered- By Function and by End-User
- Regions Covered- China, India, Japan, and the Rest of Asia-Pacific
- Key Companies Profiled- Accenture PLC, Eurofins GSC Lux SARL, Jubilant Life Science, Novo Informatics Pvt. Ltd., Infosys Ltd., and others
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- How COVID-19 will impact the market growth in 2020 and the coming years?
- Recovery Timeline
- Deviation from the pre-COVID-19 forecast
- Most affected region/segment
- Recommendations
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Asia-Pacific Drug Discovery Informatics Market – Segmentation
By Function
- Docking
- Molecular Modeling
- Libraries and Database Preparation
- Sequencing and Target Data Analysis
- Others
By End-User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organization (CRO)
- Others (Research Institutes)
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
